Rosengren, Lars

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

Rosengren, L. E., Karlsson, J., Karlsson, J., Persson, L. I., & Wikkelsø, C. (1996) · Journal of Neurochemistry

Amyotrophic Lateral Sclerosis ResearchHereditary Neurological Disorders

Cited by 499

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

Hesse, C., Rosengren, L., Andreasen, N., Davidsson, P., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (2001) · Neuroscience Letters

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 450

Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury

Öst, M., Nylén, K., Csajbok, L., Öhrfelt, A. O., Tullberg, M., Wikkelsö, C., Nellgård, P., Rosengren, L., Blennow, K., & Nellgård, B. (2006) · Neurology

Traumatic Brain Injury and Neurovascular DisturbancesTraumatic Brain Injury Research

Cited by 321

Cerebrovascular Complications in Patients with Left‐Sided Infective Endocarditis Are Common: A Prospective Study Using Magnetic Resonance Imaging and Neurochemical Brain Damage Markers

Snygg‐Martin, U., Gustafsson, L., Rosengren, L., Alsiö, Å., Ackerholm, P., Andersson, R., & Olaison, L. (2008) · Clinical Infectious Diseases

Infective Endocarditis Diagnosis and ManagementInfectious Diseases and Tuberculosis

Cited by 320

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 263

Cerebrospinal fluid -amyloid 1-42 concentration may predict cognitive decline in older women

Gustafson, D. R., Skoog, I., Rosengren, L., Zetterberg, H., & Blennow, K. (2006) · Journal of Neurology, Neurosurgery & Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 214

Neurofilament protein in cerebrospinal fluid: A marker of white matter changes

Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A. (2001) · Journal of Neuroscience Research

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 209

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K., & Wallin, A. (2000) · Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 181

Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients

Jessen Krut, J., Mellberg, T., Price, R. W., Hagberg, L., Fuchs, D., Rosengren, L., Nilsson, S., Zetterberg, H., & Gisslén, M. (2014) · PLoS ONE

HIV Research and TreatmentInfectious Diseases and Tuberculosis

Cited by 167

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

Landqvist Waldö, M., Frizell Santillo, A., Passant, U., Zetterberg, H., Rosengren, L., Nilsson, C., & Englund, E. (2013) · BMC Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 127

Mid‐life adiposity factors relate to blood–brain barrier integrity in late life

Gustafson, D. R., Karlsson, C., Skoog, I., Rosengren, L., Lissner, L., & Blennow, K. (2007) · Journal of Internal Medicine

Barrier Structure and Function StudiesAdipokines, Inflammation, and Metabolic Diseases

Cited by 107

Neurofilament ELISA validation

Petzold, A., Altintas, A., Andreoni, L., Bartos, A., Berthele, A., Blankenstein, M. A., Buee, L., Castellazzi, M., Cepok, S., Comabella, M., et al. (2010) · Journal of Immunological Methods

Clinical Laboratory Practices and Quality ControlReliability and Agreement in Measurement

Cited by 105

Higher CSF Interleukin-6 and CSF Interleukin-8 in Current Depression in Older Women. Results from a Population-Based Sample

Kern, S., Skoog, I., Börjesson-Hanson, A., Blennow, K., Zetterberg, H., Östling, S., Kern, J., Gudmundsson, P., Marlow, T., Rosengren, L., et al. (2014) · Brain, Behavior, and Immunity

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 94

Monoclonal Antibodies Selective for Low Molecular Weight Neurofilaments

Norgren, N., Karlsson, J.-E., Rosengren, L., & Stigbrand, T. (2002) · Hybridoma and Hybridomics

Skin and Cellular Biology ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 81

Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis

Zetterberg, H., Jacobsson, J., Rosengren, L., Blennow, K., & Andersen, P. M. (2008) · Journal of the Neurological Sciences

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 46

Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years

Kern, S., Skoog, I., Börjesson-Hanson, A., Blennow, K., Zetterberg, H., Östling, S., Kern, J., Gudmundsson, P., Marlow, T., Rosengren, L., et al. (2013) · Brain, Behavior, and Immunity

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 13